全文获取类型
收费全文 | 30162篇 |
免费 | 3102篇 |
国内免费 | 913篇 |
专业分类
耳鼻咽喉 | 241篇 |
儿科学 | 1341篇 |
妇产科学 | 419篇 |
基础医学 | 4793篇 |
口腔科学 | 684篇 |
临床医学 | 3051篇 |
内科学 | 4610篇 |
皮肤病学 | 556篇 |
神经病学 | 2439篇 |
特种医学 | 385篇 |
外国民族医学 | 6篇 |
外科学 | 1572篇 |
综合类 | 3392篇 |
现状与发展 | 7篇 |
预防医学 | 5121篇 |
眼科学 | 481篇 |
药学 | 1368篇 |
30篇 | |
中国医学 | 412篇 |
肿瘤学 | 3269篇 |
出版年
2024年 | 39篇 |
2023年 | 544篇 |
2022年 | 734篇 |
2021年 | 1360篇 |
2020年 | 1380篇 |
2019年 | 1310篇 |
2018年 | 1163篇 |
2017年 | 1237篇 |
2016年 | 1232篇 |
2015年 | 1257篇 |
2014年 | 1972篇 |
2013年 | 2314篇 |
2012年 | 1766篇 |
2011年 | 1876篇 |
2010年 | 1473篇 |
2009年 | 1599篇 |
2008年 | 1658篇 |
2007年 | 1556篇 |
2006年 | 1350篇 |
2005年 | 1172篇 |
2004年 | 1048篇 |
2003年 | 936篇 |
2002年 | 791篇 |
2001年 | 717篇 |
2000年 | 554篇 |
1999年 | 473篇 |
1998年 | 395篇 |
1997年 | 322篇 |
1996年 | 237篇 |
1995年 | 319篇 |
1994年 | 228篇 |
1993年 | 188篇 |
1992年 | 143篇 |
1991年 | 137篇 |
1990年 | 95篇 |
1989年 | 92篇 |
1988年 | 80篇 |
1987年 | 50篇 |
1986年 | 40篇 |
1985年 | 76篇 |
1984年 | 49篇 |
1983年 | 33篇 |
1982年 | 38篇 |
1981年 | 34篇 |
1980年 | 27篇 |
1979年 | 22篇 |
1978年 | 15篇 |
1977年 | 12篇 |
1976年 | 10篇 |
1970年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
《Journal of the American Medical Directors Association》2022,23(1):161-164
ObjectivesAs more countries are implementing measures to address Alzheimer’s disease (AD), it is essential to update the available knowledge on the relationship between economic status and mortality in patients with AD. This study examined the influence of economic status on mortality in Japanese individuals with AD using a medical claims dataset.DesignThis was a retrospective cohort study.Setting and ParticipantsMedical claims data from April 2014 to March 2019 were obtained from 13 local cities participating in the Longevity Improvement and Fair Evidence study. The inclusion criteria were patients aged 65 years and older who were newly diagnosed with AD during the study period.MethodsThe outcome was death during the follow-up period. We assessed economic status by household income (middle to high income and low income); data were obtained from the use of the Medical Expenditure Ceiling Application and Standard Copayment Reduction Card (fee reduction card) when receiving an AD diagnosis, as an indicator of low-income status. We performed multivariate Cox proportional hazards analyses to examine the relationship between economic status and mortality; the model was adjusted for age, sex, the Charlson comorbidity index, and antidementia drug use.ResultsWe identified 39,081 newly diagnosed patients with AD from the Longevity Improvement and Fair Evidence study database (mean age, 83.6 years; female, 67.1%). Of these, 3189 individuals were identified as having a low-income status. After adjusting for possible confounders, low-income status was associated with mortality (hazard ratio, 1.95; 95% confidence interval, 1.84–2.07).Conclusions and ImplicationsLow-income status was associated with substantially poorer prognoses in new AD cases, indicating a need for a thorough examination of medical and nursing care services utilized by low-income individuals with AD and to explore improvement strategies. 相似文献
22.
23.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(7):472-479
AimsTreatment decisions for older patients with breast cancer are complex and evidence is largely extrapolated from younger populations. Frailty and comorbidity need to be considered. We studied the baseline characteristics and treatment decisions in older patients in Christchurch with breast cancer and assessed survival outcomes and prognostic/discriminatory performance of several tools.Materials and methodsWe searched the Canterbury Breast Cancer Registry and identified patients aged 70 years or older at diagnosis with invasive, non-metastatic breast cancer between 1 June 2009 and 30 June 2015. We retrieved demographics, treatment and outcome information. Overall survival and breast cancer-specific survival were estimated. Tools analysing performance status and comorbidity were assessed for their prognostic and discriminatory power.ResultsIn total, 440 patients were identified. Primary surgery was carried out for 362 patients (82.3%): breast-conserving surgery in 114 (of whom 88.6% received radiation therapy); mastectomy in 248 (of whom 24.6% received radiation). Hormone therapy was given for 265 (71.1%) patients with oestrogen receptor-positive cancers. Two hundred and seventy-four (62.3%) patients received full standard treatment, which was associated with significantly improved 5-year survival and 5-year breast cancer-specific survival. The median estimated overall survival was 8.2 years (95% confidence interval 7.3–9.1 years). Of those who died, 71.3% of deaths were due to causes other than breast cancer or unknown causes. The comorbidity-adjusted life expectancy (CALE) showed partial prognostic accuracy. CALE, Charlson and Eastern Cooperative Oncology Group tools all showed discriminatory value.ConclusionIn this population-based series of older patients with breast cancer, showing high levels of primary and adjuvant treatment, patients were more likely to die of causes other than breast cancer. Performance status and comorbidity tools showed prognostic and discriminatory potential in this population supporting their use in treatment decision making. CALE showed the most potential to improve treatment decisions but requires validation in this population to improve prognostic accuracy. 相似文献
24.
25.
26.
27.
目的 了解芦山地震5年后雅安市高血压患者心理卫生问题检出率及其影响因素,为促进地震灾区高血压患者心理健康提供参考。方法 采用分层整群随机抽样方法,于2018年12月选取雅安市高血压患者800例作为研究对象。采用自编居民基本信息调查表收集患者的基本资料,采用12项一般健康问卷(GHQ-12)评定患者近期是否存在心理卫生问题,采用Logistic回归分析其影响因素。结果 回收有效问卷744份(93.00%),检出存在心理卫生问题者79例(10.62%)。单因素分析结果显示,不同婚姻状况(P?0.01)、家庭人均月收入(P=0.012)、是否接受社会救助(χ2=25.194,P?0.01)的高血压患者心理卫生问题检出率差异均有统计学意义。Logistic回归分析显示,未婚/分居/离异/丧偶(OR=3.879,P=0.015)以及接受社会救助(OR=4.705,P?0.01)是高血压患者存在心理卫生问题的危险因素。结论 雅安市高血压患者心理卫生问题检出率较低,未婚/分居/离异/丧偶者以及接受社会救助的高血压患者心理卫生问题可能更突出。 相似文献
28.
29.
探究p53 基因突变与骨髓增殖性肿瘤(MPN)临床特征及预后的关系。方法 选取2017年1月~2020年1月本院收治的MPN患者126例,二代测序法检测患者p53 基因突变情况。对患者进行随访,统计患者总生存(OS)时间和累计生存率;分析p53 基因突变对患者临床特征、预后的影响。结果 126例MPN患者中12例(9.52%)检出p53基因突变,突变主要位于4~8号外显子上,不同类型患者的p53 基因突变检出率比较差异无统计学意义(P>0.05)。p53突变组患者年龄大于p53 非突变组,WBC水平低于p53 非突变组(P<0.05),两组患者的染色体核型、IPSS预后分层比较差异无统计学意义(P>0.05);p53 非突变组患者的OS时间、累计生存率均明显高于p53突变组患者(P<0.05)。结论 MPN患者p53 基因突变发生率较高,与患者年龄、WBC水平、异常核型及IPSS预后分层相关,p53 基因突变会影响患者的预后,可作为临床筛查预后不良高风险人群的客观指标。 相似文献
30.